Claraphi Advisory Network’s Nephros NEPH Stock Holding History

Claraphi Advisory Network’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-388	Closed	-$2K	–	862
2020 Q1	$2K	Buy	+388	New	+$3.29K	﹤0.01%	1022

Other funds holding NEPH

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

OMC

Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Claraphi Advisory Network's NEPH Position: Q2 2020 in Review

Claraphi Advisory Network sold out of Nephros (NEPH) in Q2 2020, closing a stake of 388 shares — an estimated $2K sold.

Claraphi Advisory Network first reported a position in NEPH in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 21 funds tracked by Wall St. Rank hold NEPH as of Q2 2020.

Claraphi Advisory Network reported no remaining Nephros position as of Q2 2020 after selling out during the quarter.
Claraphi Advisory Network sold 388 Nephros shares in Q2 2020, an estimated $2K.
Claraphi Advisory Network first reported a position in Nephros in Q1 2020 and held it in 1 quarter.
Claraphi Advisory Network's Nephros position peaked at $2K in Q1 2020.
21 funds tracked by Wall St. Rank held Nephros as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.